Amended Statement of Ownership (sc 13g/a)
February 12 2014 - 3:33PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G/A
Under the Securities Exchange Act of
1934
(Amendment No. 1)*
Solta Medical, Inc.
(Name of Issuer)
Common Stock, par value $0.001 par
value
(Title of Class of Securities)
83438K103
(CUSIP Number)
December 31, 2013
(Date of Event Which Requires Filing of
this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
*The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No.
83438K103
|
13G
|
Page 2 of 9 Pages
|
1. Names of Reporting Persons.
Longitude Capital Partners, LLC
|
2. Check the Appropriate Box if a Member of a Group (see instructions)
(a)
o
(b)
o
|
3. SEC Use Only
|
4. Citizenship or Place of Organization
Delaware
|
Number of Shares
Beneficially
Owned by
Each Reporting
Person With:
|
5. Sole Voting Power
0
|
6. Shared Voting Power
0
|
7. Sole Dispositive Power
0
|
8. Shared Dispositive Power
0
|
9. Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (see instructions)
o
|
11. Percent of Class Represented by Amount in Row 9
0.0%
|
12. Type of Reporting Person (see instructions)
OO
|
CUSIP No.
83438K103
|
13G
|
Page 3 of 9 Pages
|
1. Names of Reporting Persons.
Longitude Venture Partners, L.P.
|
2. Check the Appropriate Box if a Member of a Group (see instructions)
(a)
o
(b)
o
|
3. SEC Use Only
|
4. Citizenship or Place of Organization
Delaware
|
Number of Shares
Beneficially
Owned by
Each Reporting
Person With:
|
5. Sole Voting Power
0
|
6. Shared Voting Power
0
|
7. Sole Dispositive Power
0
|
8. Shared Dispositive Power
0
|
9. Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (see instructions)
o
|
11. Percent of Class Represented by Amount in Row 9
0.0%
|
12. Type of Reporting Person (see instructions)
PN
|
CUSIP No.
83438K103
|
13G
|
Page 4 of 9 Pages
|
1. Names of Reporting Persons.
Longitude Capital Associates, L.P.
|
2. Check the Appropriate Box if a Member of a Group (see instructions)
(a)
o
(b)
o
|
3. SEC Use Only
|
4. Citizenship or Place of Organization
Delaware
|
Number of Shares
Beneficially
Owned by
Each Reporting
Person With:
|
5. Sole Voting Power
0
|
6. Shared Voting Power
0
|
7. Sole Dispositive Power
0
|
8. Shared Dispositive Power
0
|
9. Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (see instructions)
o
|
11. Percent of Class Represented by Amount in Row 9
0.0%
|
12. Type of Reporting Person (see instructions)
PN
|
CUSIP No.
83438K103
|
13G
|
Page 5 of 9 Pages
|
1. Names of Reporting Persons.
Patrick G. Enright
|
2. Check the Appropriate Box if a Member of a Group (see instructions)
(a)
o
(b)
o
|
3. SEC Use Only
|
4. Citizenship or Place of Organization
United States
|
Number of Shares
Beneficially
Owned by
Each Reporting
Person With:
|
5. Sole Voting Power
0
|
6. Shared Voting Power
0
|
7. Sole Dispositive Power
0
|
8. Shared Dispositive Power
0
|
9. Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (see instructions)
o
|
11. Percent of Class Represented by Amount in Row 9
0.0%
|
12. Type of Reporting Person (see instructions)
IN
|
CUSIP No.
83438K103
|
13G
|
Page 6 of 9 Pages
|
1. Names of Reporting Persons.
Juliet Tammenoms Bakker
|
2. Check the Appropriate Box if a Member of a Group (see instructions)
(a)
o
(b)
o
|
3. SEC Use Only
|
4. Citizenship or Place of Organization
United States
|
Number of Shares
Beneficially
Owned by
Each Reporting
Person With:
|
5. Sole Voting Power
0
|
6. Shared Voting Power
0
|
7. Sole Dispositive Power
0
|
8. Shared Dispositive Power
0
|
9. Aggregate Amount Beneficially Owned by Each Reporting Person
0
|
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares (see instructions)
o
|
11. Percent of Class Represented by Amount in Row 9
0.0%
|
12. Type of Reporting Person (see instructions)
IN
|
|
Item 1(a).
|
Name of Issuer:
|
Solta Medical, Inc.
|
Item 1(b).
|
Address of Issuer's Principal Executive Offices:
|
25881 Industrial Boulevard
Hayward, California 94545
|
Item 2(a).
|
Name of Person Filing:
|
This Amendment
No. 1 to Schedule 13G amends the Schedule 13G (the “Statement”) initially filed with the Securities and
Exchange Commission on January 19, 2010 and is being jointly filed by Longitude Venture Partners, L.P. (“LVP”);
Longitude Capital Associates, L.P. (“LCA”); each of LVP’s and LCA’s sole general partner, Longitude
Capital Partners, LLC (“LCP”); and individuals Patrick G. Enright and Juliet Tammenoms Bakker (each such
individual, LVP, LCA and LCP, a “Reporting Person” and collectively, the “Reporting Persons”).
The Reporting Persons
have entered into a Joint Filing Agreement, dated January 19, 2010, a copy of which is filed with the Statement, pursuant
to which the Reporting Persons have agreed to file the Statement and all amendments thereto jointly in accordance with the provisions
of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
|
Item 2(b)
|
Address of Principal Business Office, or if None,
Residence:
|
The address of the principal
business office of each Reporting Person is 800 El Camino Real, Suite 220, Menlo Park, California 94025.
See Item 4 of each cover
page.
|
Item 2(d).
|
Title of Class of Securities:
|
Common Stock, par value
$0.001 per share (the “Common Stock).
83438K103
|
Item 3.
|
If this statement is filed pursuant to §§
240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
|
Not applicable
As of December 31, 2013,
each Reporting Person had sole or shared power to direct the vote of and sole or shared power to dispose or direct the disposition
of zero shares of Common Stock and, as a result, beneficially owned zero shares of Common Stock and 0.0% of the outstanding shares
of Common Stock.
All of the securities
of the Issuer previously reported in the Statement as beneficially owned by the Reporting Persons were sold in open market transactions
during the 2013 calendar year. Neither the filing of the Statement or this amendment thereto nor any of its contents shall be deemed
to constitute an admission that any of the Reporting Persons was, for any other purpose, the beneficial owner of any of such securities,
and each of the Reporting Persons disclaimed beneficial ownership as to such securities, except to the extent of his, her or its
pecuniary interests therein.
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
If this statement is
being filed to report the fact that as of the date hereof each of the Reporting Persons has ceased to be the beneficial owner of
more than five percent of the class of securities, check the following
x
.
|
Item 6.
|
Ownership of More Than Five Percent on Behalf of Another
Person.
|
Not Applicable.
|
Item 7.
|
Identification and Classification of the Subsidiary
Which Acquired the Security Being Reported on By the Parent Holding Company.
|
Not Applicable.
|
Item 8.
|
Identification and Classification of Members of the
Group.
|
Not Applicable.
|
Item 9.
|
Notice of Dissolution of the Group.
|
Not Applicable.
By signing below I certify
that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection
with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated: February 12, 2014
|
|
LONGITUDE VENTURE PARTNERS, L.P.
|
|
|
|
|
|
|
By:
|
LONGITUDE CAPITAL PARTNERS, LLC
|
|
|
Its:
|
General Partner
|
|
|
|
|
/s/ Patrick G. Enright
|
|
By:
|
/s/ Patrick G. Enright
|
Patrick G. Enright
|
|
|
Patrick G. Enright, Managing Member
|
|
|
|
|
|
|
LONGITUDE CAPITAL ASSOCIATES, L.P.
|
|
|
|
|
|
|
By:
|
LONGITUDE CAPITAL PARTNERS, LLC
|
|
|
Its:
|
General Partner
|
|
|
|
|
/s/ Juliet Tammenoms Bakker
|
|
By:
|
/s/ Patrick G. Enright
|
Juliet Tammenoms Bakker
|
|
|
Patrick G. Enright, Managing Member
|
|
|
|
|
|
|
LONGITUDE CAPITAL PARTNERS, LLC
|
|
|
|
|
|
|
By:
|
/s/ Patrick G. Enright
|
|
|
|
Patrick G. Enright, Managing Member
|
|
|
|
|
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From Apr 2024 to May 2024
Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart
From May 2023 to May 2024